HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Northland Securities increased their Q2 2027 earnings per share estimates for HIVE Blockchain Technologies in a research report issued to clients and investors on Monday, August 17th. Northland Securities analyst M. Grondahl now anticipates that the company will post earnings of ($0.21) per share for the quarter, up from their previous estimate of ($0.26). Northland Securities also issued estimates for HIVE Blockchain Technologies’ Q3 2027 earnings at ($0.19) EPS, Q4 2027 earnings at ($0.14) EPS and FY2027 earnings at ($0.80) EPS.
Separately, Chardan Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Monday, July 27th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy”.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
